FDA grants orphan label to eye cancer chemo-delivery combo FierceDrugDelivery The company also uses the delivery system in treatments for inflammation associated with cataract surgery, cystoid macular edema, glaucoma, macular degeneration, uveitis and cornea transplant rejection. Icon is collaborating with Memorial Sloan ... |
